Disc Medicine, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, IRON reported earnings of -1.77 USD per share (EPS) for Q3 25, missing the estimate of -1.49 USD, resulting in a -18.56% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.48% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analistas forecast an EPS of -1.78 USD, with revenue projected to reach -- USD, implying an aumentar of 0.56% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Disc Medicine, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Disc Medicine, Inc. Common Stock reported EPS of -$1.77, missing estimates by -18.56%, and revenue of $0.00, 0% as expectations.
How did the market react to Disc Medicine, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.48%, changed from $88.31 before the earnings release to $87.00 the day after.
When is Disc Medicine, Inc. Common Stock expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for Disc Medicine, Inc. Common Stock's next earnings report?
Based on 15
analistas, Disc Medicine, Inc. Common Stock is expected to report EPS of -$1.78 and revenue of -- for Q4 2025.